Dawnrays Pharmaceutical Holdings Ltd (2348)

Hong Kong
Currency in HKD
1.180
-0.020(-1.67%)
Closed
2348 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
1.1801.200
52 wk Range
1.0901.400
Key Statistics
Edit
Bid/Ask
1.18 / 1.20
Prev. Close
1.2
Open
1.2
Day's Range
1.18-1.2
52 wk Range
1.09-1.4
Volume
56K
Average Volume (3m)
168.22K
1-Year Change
-10.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2348 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
No news in this category
Looks like there are no results in this news category

Dawnrays Pharmaceutical Holdings Ltd Company Profile

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.

Employees
1175
Market
Hong Kong

Compare 2348 to Peers and Sector

Metrics to compare
2348
Peers
Sector
Relationship
P/E Ratio
2.9x29.6x−0.5x
PEG Ratio
0.11−0.340.00
Price/Book
0.5x1.9x2.6x
Price / LTM Sales
1.5x2.8x3.0x
Upside (Analyst Target)
-24.7%55.2%
Fair Value Upside
Unlock4.3%9.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.38%
Dividend Yield
6.78%
Industry Median 2.78%
Annualized payout
0.08
Paid unevenly
5-Years Growth
+1.83%
Growth Streak

Earnings

Latest Release
Apr 16, 2018
EPS / Forecast
0.18 / --
Revenue / Forecast
391.40M / --
EPS Revisions
Last 90 days

FAQ

What Is the Dawnrays Pharma (2348) Stock Price Today?

The Dawnrays Pharma stock price today is 1.18

What Stock Exchange Does Dawnrays Pharma Trade On?

Dawnrays Pharma is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Dawnrays Pharma?

The stock symbol for Dawnrays Pharma is "2348."

Does Dawnrays Pharma Pay Dividends? What’s The Current Dividend Yield?

The Dawnrays Pharma dividend yield is 6.78%.

What Is the Dawnrays Pharma Market Cap?

As of today, Dawnrays Pharma market cap is 1.77B.

What is Dawnrays Pharma Earnings Per Share?

The Dawnrays Pharma EPS is 0.375.

From a Technical Analysis Perspective, Is 2348 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.